Home > Research Institute > Available Trials > Seribantumab in patients with NRG1+ locally advanced or metastatic solid tumors
Seribantumab in patients with NRG1+ locally advanced or metastatic solid tumors
A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors
Disease Types: Solid Tumors
Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville
A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors
For More Information: